Address |
11 Hurley Street Cambridge Massachusetts 02142 United States |
Employees | - |
Website | http://www.editasmedicine.com |
Updated | 07/08/2019 |
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. |